Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
TROSPIUM CHLORIDE
Auden Mckenzie (Pharma Division) Ltd
G04BD09
TROSPIUM CHLORIDE
20 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Drugs for urinary frequency and incontinence
Transfer Pending
2011-06-17
continued... please turn over PATIENT INFORMATION LEAFLET PACKAGE LEAFLET A1000167/2 Back of leaflet TROSPIUM CHLORIDE 20MG FILM-COATED TABLETS IN THIS LEAFLET 1. What is Trospium Chloride and what is it used for? 2. Before you take Trospium Chloride 3. How to take Trospium Chloride 4. Possible side effects 5. Storing Trospium Chloride 6. Further information 1. WHAT IS TROSPIUM CHLORIDE AND WHAT IS IT USED FOR? 2. BEFORE YOU TAKE TROSPIUM CHLORIDE 3. HOW TO TAKE TROSPIUM CHLORIDE 4. POSSIBLE SIDE EFFECTS 5. STORING TROSPIUM CHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. DO NOT TAKE TROSPIUM CHLORIDE IF YOUR DOCTOR HAS TOLD YOU THAT YOU HAVE: • An allergic reaction to Trospium Chloride or any of the ingredients listed in section 6. (An allergic reaction can be a rash, itchiness or shortness of breath). • Urinary retention i.e. urination occurs less frequently than normal. • The eye condition glaucoma. • Abnormal/faster than normal heart beats. • Myasthenia gravis (a disorder which causes muscle fatigue). • A severe gastro-intestinal condition, such as toxic megacolon. DO NOT GIVE THIS PRODUCT TO CHILDREN UNDER 12 YEARS OF AGE. SPECIAL PRECAUTIONS Check with your doctor or pharmacist before taking your medicine if you suffer from any of the following: • Any type of stomach or bowel obstruction. • Blockage of the urinary tract. • Neuropathy i Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Trospium Chloride 20mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each coated tablet contains 20 mg trospium chloride. Excipient: Each tablet contains 71 mg of lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated Tablet. Yellow, round tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION One coated tablet twice daily (equivalent to 40 mg of trospium chloride per day). In patients with severe renal impairment (creatinine clearance between 10 and 30 ml/min/1.73 m 2 ) the recommended dosage is: One coated tablet per day or every second day (equivalent to 20 mg of trospium chloride per day or every second day). The coated tablet should be swallowed whole with a glass of water before meals on an empty stomach. The need for continued treatment should be reassessed at regular intervals of 3-6 months. Since no data are available, use in children under 12 years of age is contra-indicated. 4.3 CONTRAINDICATIONS Trospium chloride is contra-indicated in patients with urinary retention, severe gastro-intestinal condition (including toxic megacolon), myasthenia gravis, narrow-angle glaucoma and tachyarrhythmia. Trospium chloride is also contra-indicated in patients who have demonstrated hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Trospium chloride should be used with caution by patients: with obstructive conditions of the gastro-intestinal tract such as pyloric Lugege kogu dokumenti